In short

A buy-sell agreement sets the price, timing, and tax treatment when a retiring shareholder exits a closely-held business. A cross-purchase by remaining owners generally gives cleaner CGT treatment than an entity share buy-back, which can create a partly-taxable deemed dividend, and reviewing valuation formulas and insurance funding years before exit prevents a stale agreement from costing hundreds of thousands.

For Australian retirees who are partners or shareholders in closely-held businesses — professional practices, family operating companies, multi-shareholder service businesses, partnerships — the buy-sell agreement that governs their exit is one of the most consequential financial documents they will ever sign. The buy-sell (sometimes a shareholders' agreement, partnership agreement, or cross-purchase agreement) pre-determines how a retiring owner's interest will be acquired by the remaining owners or by the entity itself: the price, the timing, the method of payment, the funding mechanism (often cross-life insurance), and the tax treatment. A well-structured buy-sell delivers a smooth, fair and tax-efficient exit aligned with the owner's retirement plan; a stale or poorly drafted one produces valuation disputes, drawn-out exits, a lower realised price, and tax outcomes nobody anticipated. For retirees whose business equity is often the single largest item on their personal balance sheet, reviewing and updating the buy-sell well before the planned exit is essential.

The basic structure is simple in concept. The agreement names one or more triggering events — typically death, permanent incapacity, retirement (often age-based, from 60 or 65), voluntary exit, bankruptcy, or a family breakdown affecting shareholding. When a trigger occurs, the agreement requires either the entity (an entity-purchase or company buy-back) or the remaining owners (a cross-purchase) to acquire the exiting owner's interest at a price set by the valuation provisions. It usually also carries restraint-of-trade and confidentiality clauses and a dispute-resolution mechanism. In most closely-held businesses the buy-sell is a separate contract layered alongside the company constitution or partnership deed, though smaller entities may fold the terms into a single document.

The valuation provisions are the part that matters most, and the common approaches each trade off certainty against fairness. A fixed price updated periodically by the owners gives certainty but goes stale fast and can produce wildly unfair results if neglected. A formula — a multiple of EBITDA, gross fees, or net asset value — is predictable but may drift from economic reality as goodwill grows. An independent valuation at the time of exit is fair but slow, costly, and itself open to dispute. Mutual agreement between exiting and remaining owners, with arbitration as a backstop, is simple but unreliable in an adversarial exit. Best practice is usually to combine them — a formula as the default, with an independent valuation as a backstop where the formula produces an unfair figure or where price certainty is critical (such as a death-triggered exit that insurance must fund).

The funding mechanism decides whether the buyout can actually be paid. Cash from accumulated business reserves works for mature practices that set funds aside. Cross-life insurance — each owner insured by the others, with the proceeds funding a buyout on death — is the standard for death-triggered exits, and total and permanent disability (TPD) insurance plays the same role for disability triggers. Vendor finance or instalment payments, where the entity or remaining owners pay the exiting owner over time, is common for retirement exits where insurance doesn't apply, and the instalment terms (interest rate, security, period) then matter a great deal. Some businesses use external borrowing or a pre-funded sinking fund instead. For death and disability, insurance is generally the cleanest; for retirement, vendor finance or reserves usually carry the load.

The entity-purchase versus cross-purchase choice has real tax consequences for the retiring owner. Under an entity-purchase (an off-market share buy-back), the company itself acquires the shares; the Corporations Act 2001 buy-back rules apply, and for a private company the buy-back price is split into a deemed-dividend component (the amount not debited to the share capital account, assessed as a dividend) and a capital-proceeds component for CGT. (The 2022 change that removed the dividend component from off-market buy-backs applies only to listed public companies, so it doesn't help a closely-held business.) Under a cross-purchase, the remaining shareholders buy the shares personally, and the seller simply has a CGT event with full capital treatment — no dividend split. For owners eligible for the small business CGT concessions under Division 152 of the ITAA 1997, the cross-purchase usually delivers the cleaner outcome, because the whole gain can access the concessions, whereas the deemed-dividend slice of a buy-back cannot. The cross-purchase is generally preferred for a retiring owner, though the right answer depends on the entity's accumulated profits, franking position, and the buyers' cash flow.

The small business CGT concessions are where good buy-sell design pays off most. For an owner aged 55 or over who has held the asset for at least 15 years, whose entity meets the basic conditions (the $6M net asset value test or the $2M turnover test, plus the active asset and significant-individual requirements), and who is exiting in connection with retirement, the 15-year exemption can make the entire capital gain tax-free regardless of size. The proceeds can then go into super under the CGT cap, which is $1,865,000 for FY25-26, over and above the ordinary non-concessional cap. Where the 15-year test isn't met, the retirement exemption disregards up to a $500,000 lifetime limit per individual. The buy-sell terms have to support all this: the contract date falling after the 55th birthday and the 15-year mark, a share sale rather than a deemed-dividend buy-back, and cash flow that allows the super contribution to be made on time.

The insurance alignment is the most commonly mishandled aspect in practice. The agreement gets updated to a higher valuation but the cross-life cover is not increased, leaving a shortfall on a death-triggered exit; or the policy is held in the wrong name for the chosen structure; or it has lapsed because of a change in one owner's health; or the beneficiary nominations are stale. The fix is an annual insurance audit with cover amounts tracking the business value. The cost of getting this wrong is real — a funding mismatch on death can delay the buyout, force asset sales, or leave the deceased owner's estate with less than the agreed value.

The family-business Centrelink interaction is where a common myth needs correcting. Where a retiring parent sells shares to adult children at below-market value, the shortfall is assessed under Centrelink's ordinary deprivation (gifting) rules — and there is no special small business exemption. Disposing of an asset for less than market value counts as a gift regardless of whether the buyer is family or a stranger. A person can give away up to $10,000 a financial year and $30,000 over five years without it affecting their pension; anything above those limits is treated as a "deprived asset" for five years and deemed to earn income. For a retiree relying on the Age Pension, the Centrelink effect of a below-market family buy-sell can matter as much as the tax effect, and it should be modelled before the agreement is finalised — not discovered afterwards.

What do worked planning examples show?

These two cases show how buy-sells affect retirement-phase shareholders. Illustrative only — not personal advice — using FY25-26 figures.

Case 1 — David, 64, an equity partner in a six-partner consulting firm for 22 years. The buy-sell, drafted in 2005, values exits at revenue × 2.0. Revenue has grown fourfold since 2005 but the formula has never been updated, so it values David's exit at about $850,000 when a market valuation would be closer to $2.2M. On these facts David's planned retirement in 18 months would deliver a buyout roughly $1.35M below fair value, and the remaining partners — who benefit from the stale formula — have little incentive to update it. His realistic options are to negotiate an updated buy-sell now (which needs the others' cooperation), to take the formula exit but supplement it with legitimate remuneration in his final years (consulting fees, accelerated bonuses), or to restructure the timing of his exit. On these facts the rational move is to open the update discussion immediately and document the discrepancy while he still has leverage as an active partner. The broader lesson is that a partner's buy-sell should be reviewed years before retirement, while the cooperation of the remaining owners can still be secured.

Case 2 — Margaret, 67, sole director and 60% shareholder of a family operating company; her two adult children hold 20% each and work in the business. She plans to sell her 60% to the company in an entity-purchase for $1.4M. She acquired the shares 12 years ago in a restructure, and the company's net assets are about $4.5M. Several issues collide here. The 12-year holding period falls short of the 15-year exemption, so that concession isn't available — but at 67 (well over 55) Margaret can use the retirement exemption (up to the $500,000 lifetime limit), which at her age she can take as cash without having to contribute it to super. The entity-purchase will likely create a deemed-dividend component that needs to be modelled, and the basic conditions look satisfied (net assets under $6M, significant individual). On these facts the options worth weighing are delaying the sale by three years to reach the 15-year mark — potentially turning a partial-concession result into a fully exempt one — or restructuring as a cross-purchase by the children rather than a company buy-back, which avoids the deemed-dividend slice and gives Margaret cleaner CGT treatment. Specialist tax advice is essential: the gap between a 12-year and a 15-year holding can be worth hundreds of thousands of dollars.

For retirees with equity in closely-held businesses, the buy-sell agreement ultimately determines both the exit value and the tax outcome. The advice work is to review it well before retirement, update stale valuation provisions, confirm the insurance funding matches the agreement, time the exit to satisfy the small business CGT concession conditions, structure the buyout (cross-purchase versus entity-purchase) for the best tax result, model the CGT cap super contribution, and check the Centrelink deprivation position on any below-market family transfer. Too often the buy-sell is signed once at the start of the business and never revisited — by which time the exit is imminent and the structure can no longer be optimised. A proactive review three to five years out is the high-value intervention.

Sources


Key takeaways

  • A buy-sell agreement's valuation formula can go badly stale over the years, sometimes leaving a retiring shareholder with a buyout price far below current fair value.
  • An entity-purchase (company share buy-back) can create a deemed-dividend component that isn't eligible for the small business CGT concessions, unlike a cross-purchase by remaining shareholders.
  • The small business 15-year exemption can make an entire exit gain tax-free for an owner 55+ who has held the interest at least 15 years and is exiting in connection with retirement.
  • Cross-life insurance funding a death-triggered buyout needs regular review — cover amounts often fail to keep pace with an updated business valuation.
  • Selling shares to family at below-market value is assessed under Centrelink's standard $10,000/$30,000 deprivation rules, with no special small business exemption.

Frequently asked questions

Why does it matter whether my exit is structured as a company buy-back or a sale to the other shareholders?

A company buy-back (entity-purchase) of shares in a private company can split the price into a deemed-dividend component and a capital-proceeds component, and the dividend part can't access the small business CGT concessions. A cross-purchase, where the remaining shareholders buy your shares personally, is treated as a straightforward CGT event with full capital treatment, so the whole gain can potentially access the concessions.

How often should a buy-sell agreement's valuation formula be reviewed?

Ideally every few years, and certainly well before any planned exit. A formula set when the business was much smaller can badly understate its current value, and the remaining owners — who benefit from a low buyout price — often have little incentive to update it voluntarily, so the review needs to start years ahead of retirement while the exiting owner still has negotiating leverage.

Can I get the small business 15-year CGT exemption when I exit under a buy-sell agreement?

Potentially, if you're 55 or over, have held the interest for at least 15 years, your entity meets the basic conditions, and you're exiting in connection with retirement. The buy-sell needs to support this — for example, the exit needs to be a genuine share sale rather than a deemed-dividend buy-back, and the contract date needs to fall after both the 55th birthday and the 15-year mark.

Does selling my business shares to my children at a discount affect my Age Pension?

Yes, and there's no special exemption just because the buyer is family. The shortfall between market value and what your children pay is assessed as a gift under Centrelink's standard deprivation rules — up to $10,000 a year or $30,000 over five years is allowed, with anything above that treated as a deprived asset and deemed to earn income for five years.

A note on advice. This article is general information only and doesn't account for your personal circumstances. Everyone's situation is different — before acting, it's worth talking it through with a licensed adviser who knows your full picture.